Discontinuation report RAN-OLANZAPINE ODT
Report ID | 91281 |
Drug Identification Number | 02414120 |
Brand name | RAN-OLANZAPINE ODT |
Common or Proper name | RAN-OLANZAPINE ODT |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 20MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 28 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2019-08-09 |
Remaining supply date | 2019-08-09 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2019-08-10 | English | Compare |
v2 | 2019-08-09 | French | Compare |
v1 | 2019-08-09 | English | Compare |
Showing 1 to 3 of 3